Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting synaptogyrin-3 in tauopathy treatment

Targeting synaptogyrin-3 in tauopathy treatment

US Patent 11332526 · Granted May 17, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Means and methods for treatment of early-onset Parkinson's disease2021
Single domain antibodies capable of modulating BACE activity2019
Single domain antibodies capable of modulating BACE activity2018
Restoring phosphorylation of a novel PINK1 substrate to treat parkinson's diseas2018
Method and apparatus for the imaging of a labeled biological sample2017
BACE1 inhibitory antibodies2015
Single domain antibodies capable of modulating BACE activity2013